Prelude Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Prelude Capital Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,225	Closed	-$5K	–	1392
2022 Q3	$5K	Hold	11,225	–	–	﹤0.01%	1357
2022 Q2	$5K	Hold	11,225	–	–	﹤0.01%	1639
2022 Q1	$7K	Buy	+11,225	New	+$6.12K	﹤0.01%	1635

Other funds holding DRTSW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Prelude Capital Management's DRTSW Position: Q4 2022 in Review

Prelude Capital Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2022, closing a stake of 11,225 shares — an estimated $5K sold.

Prelude Capital Management first reported a position in DRTSW in Q1 2022 and held it in 3 quarters. The position peaked at $7K in Q1 2022. 34 funds tracked by Wall St. Rank hold DRTSW as of Q4 2022.

Prelude Capital Management reported no remaining Alpha Tau Medical Warrant position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 11,225 Alpha Tau Medical Warrant shares in Q4 2022, an estimated $5K.
Prelude Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 3 quarters.
Prelude Capital Management's Alpha Tau Medical Warrant position peaked at $7K in Q1 2022.
34 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.